Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection

• Main Authors: Hussien Ahmed (Author), Abdelrahman Ibrahim Abushouk (Author), Mohamed Gadelkarim (Author), Arwa Mohamed (Author), Mohamed Gabr (Author), Ahmed Negida (Author)
• Format: Book
• Published: Bangladesh Pharmacological Society, 2017-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Clinical trials evaluating the safety and efficacy of daclatasvir for chronic hepatitis C virus (HCV) genotype 4 infection are scarce and yet with small sample sizes. Therefore, we conducted this systematic review to investigate the efficacy of daclatasvir in HCV genotype 4 treatment. A computer lit...